SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014800
Filing Date
2022-08-04
Accepted
2022-08-04 16:33:37
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20220630.htm   iXBRL 10-Q 2788599
2 EX-31.1 lbph-ex31_1.htm EX-31.1 21392
3 EX-31.2 lbph-ex31_2.htm EX-31.2 21405
4 EX-32.1 lbph-ex32_1.htm EX-32.1 22446
5 GRAPHIC img8593888_0.jpg GRAPHIC 391690
  Complete submission text file 0000950170-22-014800.txt   9710921

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lbph-20220630_lab.xml EX-101.LAB 384726
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lbph-20220630_def.xml EX-101.DEF 152975
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lbph-20220630_cal.xml EX-101.CAL 38371
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lbph-20220630.xsd EX-101.SCH 43690
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lbph-20220630_pre.xml EX-101.PRE 290418
54 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20220630_htm.xml XML 1730767
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 221137208
SIC: 2834 Pharmaceutical Preparations